NPI: 1962963199 · WHITEHALL, PA 18052 · Pediatrics Physician · NPI assigned 03/29/2019
Authorized official STEPHENS, JENNIFER controls 20+ related entities in our dataset. Read more
| Authorized Official | STEPHENS, JENNIFER (SR VP & CHIEF VALUE OFFICER) |
| Parent Organization | LEHIGH VALLEY PHYSICIAN GROUP |
| NPI Enumeration Date | 03/29/2019 |
Other providers sharing the same authorized official: STEPHENS, JENNIFER
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 887 | $38K |
| 2020 | 11,191 | $848K |
| 2021 | 67,960 | $5.00M |
| 2022 | 67,203 | $5.21M |
| 2023 | 69,646 | $5.71M |
| 2024 | 63,284 | $5.05M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| S9083 | Global fee urgent care centers | 180,665 | 172,535 | $20.55M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 51,532 | 48,491 | $678K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9,965 | 9,305 | $259K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6,035 | 5,876 | $156K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 12,170 | 11,539 | $65K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4,304 | 4,003 | $44K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 7,367 | 7,047 | $43K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2,768 | 2,640 | $42K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 154 | 145 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 204 | 196 | $2K |
| 99000 | 224 | 192 | $792.83 | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 26 | 26 | $608.19 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 51 | 49 | $495.16 |
| 81003 | 622 | 608 | $342.78 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 291 | 282 | $248.71 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 230 | 192 | $158.11 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,316 | 1,245 | $10.86 |
| 3080F | 38 | 37 | $0.00 | |
| 3079F | 209 | 202 | $0.00 | |
| 3074F | 159 | 150 | $0.00 | |
| 86580 | 89 | 79 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 694 | 682 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 661 | 642 | $0.00 |
| 3075F | 70 | 67 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 33 | 28 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 25 | 25 | $0.00 |
| T1015 | Clinic visit/encounter, all-inclusive | 54 | 53 | $0.00 |
| 99421 | 46 | 40 | $0.00 | |
| 3078F | 88 | 85 | $0.00 | |
| 3077F | 81 | 81 | $0.00 |